Alpha-adrenoreceptor antagonists

GG 623 GG 623 Pill - pink capsule-shape, 16mm

Pill with imprint GG 623 GG 623 is Pink, Capsule-shape and has been identified as Terazosin Hydrochloride 5 mg. It is supplied by Sandoz Pharmaceuticals Inc.

Terazosin is used in the treatment of Benign Prostatic Hyperplasia; High Blood Pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Terazosin (Terazosin [ ter-ay-zo-sin ])-GG 623 GG 623-5 mg-Pink-Capsule-shape
Terazosin (Terazosin [ ter-ay-zo-sin ])-GG 623 GG 623-5 mg-Pink-Capsule-shape
Terazosin (Terazosin [ ter-ay-zo-sin ])-GG 623 GG 623-5 mg-Pink-Capsule-shape

Terazosin
Generic Name: terazosin [ ter-ay-zo-sin ]
Imprint: GG 623 GG 623
Strength: 5 mg
Color: Pink
Size: 16.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Alpha-adrenoreceptor antagonists Antiadrenergic agents, peripherally acting
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Corn starch, Crospovidone, D&C Yellow No. 10, D&C Red No. 28, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, Gelatin, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Shellac, Propylene glycol, Ferrosoferric oxide, Titanium dioxide,
Latest News
Related Drugs